Kyowa Kirin International Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 708

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 9

  • Investments
  • 5

Kyowa Kirin International General Information

Description

Developer of prescription medicines for the treatment of unmet therapeutic needs. The company develops prescription medicines with a therapeutic focus on bone diseases, women's health and issues relating to the aging male.

Contact Information

Formerly Known As
Strakan Group, ProStrakan
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Galabank Business Park
  • Galashiels TD1 1QH
  • Scotland, United Kingdom
+44 01896
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • Galabank Business Park
  • Galashiels TD1 1QH
  • Scotland, United Kingdom
+44 01896

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyowa Kirin International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kyowa Kirin International‘s full profile, request access.

Request a free trial

Kyowa Kirin International Patents

Kyowa Kirin International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0400259-D0 Osteogenic treatments Inactive 07-Jan-2004
AU-2002317999-A1 Transdermal delivery of 5-ht3 antagonists Inactive 03-Aug-2001
WO-2003013482-A1 Transdermal delivery of 5-ht3 antagonists Inactive 03-Aug-2001
GB-0119012-D0 Transdermal delivery of drugs Inactive 03-Aug-2001
GB-0029018-D0 Dermatological formulations Inactive 28-Nov-2000 A61K31/7056
To view Kyowa Kirin International’s complete patent history, request access »

Kyowa Kirin International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kyowa Kirin International Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kyowa Kirin International‘s full profile, request access.

Request a free trial

Kyowa Kirin International Investments & Acquisitions (5)

Kyowa Kirin International’s most recent deal was a Corporate Asset Purchase with AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) for . The deal was made on 01-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AstraZeneca (Rights to Moventig in The EU, Iceland, Norway, Switzerland and Liechtenstein) 01-Mar-2016 Corporate Asset Purchase Buildings and Property
Archimedes Pharma 06-Aug-2014 Merger/Acquisition Pharmaceuticals
GTx (Fareston) 01-Oct-2012 Corporate Asset Purchase Buildings and Property
ProSkelia 01-Jun-2004 Buyout/LBO Drug Discovery
ProStrakan Pharma 16-Jan-2004 Buyout/LBO Drug Delivery
To view Kyowa Kirin International’s complete investments and acquisitions history, request access »

Kyowa Kirin International Exits (1)

Kyowa Kirin International’s most recent exit was on 01-Jun-2004 from ProSkelia. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
ProSkelia 01-Jun-2004 Completed
  • 5 buyers
To view Kyowa Kirin International’s complete exits history, request access »

Kyowa Kirin International Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Orchard Therapeutics London, United Kingdom 2015
Archimedes Pharma Reading, United Kingdom 2005
Archimedes Pharma UK Reading, United Kingdom 1996
Kyowa Kirin International (Certain International Assets) Galashiels, United Kingdom

Kyowa Kirin International FAQs

  • When was Kyowa Kirin International founded?

    Kyowa Kirin International was founded in 1995.

  • Where is Kyowa Kirin International headquartered?

    Kyowa Kirin International is headquartered in Galashiels, United Kingdom.

  • What is the size of Kyowa Kirin International?

    Kyowa Kirin International has 708 total employees.

  • What industry is Kyowa Kirin International in?

    Kyowa Kirin International’s primary industry is Drug Discovery.

  • Is Kyowa Kirin International a private or public company?

    Kyowa Kirin International is a Private company.

  • What is the current valuation of Kyowa Kirin International?

    The current valuation of Kyowa Kirin International is .

  • What is Kyowa Kirin International’s current revenue?

    The current revenue for Kyowa Kirin International is .

  • How much funding has Kyowa Kirin International raised over time?

    Kyowa Kirin International has raised $198M.

  • Who are Kyowa Kirin International’s investors?

    3i Group, Aberforth Partners, LMS Capital, Warburg Pincus, and Westpool Investment Trust have invested in Kyowa Kirin International.

  • When was Kyowa Kirin International acquired?

    Kyowa Kirin International was acquired on 17-Jun-2011.

  • Who acquired Kyowa Kirin International?

    Kyowa Kirin International was acquired by Kyowa Kirin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process